Cleared Special

K011213 - MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM (FDA 510(k) Clearance)

May 2001
Decision
26d
Days
Class 2
Risk

K011213 is an FDA 510(k) clearance for the MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM. This device is classified as a Electrode, Ion Specific, Sodium (Class II - Special Controls, product code JGS).

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on May 16, 2001, 26 days after receiving the submission on April 20, 2001.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1665.

Submission Details

510(k) Number K011213 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 2001
Decision Date May 16, 2001
Days to Decision 26 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JGS — Electrode, Ion Specific, Sodium
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1665